Selenium May Reduce the Risk of Heart Disease and Some Cancers

Reduced risk of heart disease and reduced risk of some cancers. Increasing the daily intake of selenium among individuals with low selenium status may reduce the risk of cardiovascular disease and some cancers. The available data seem to show that most adults in the Nordic and Baltic countries, with the exception of adults in Finland, have low selenium intakes and low selenium status [Alexander & Olsen 2023].

Jan Alexander
Prof. Jan Alexander, MD, PhD, Norwegian Institute of Public Health in Oslo, says: There are various factors that influence cardiovascular disease mortality and cancer incidence: diet, lifestyle, genetics, inter alia. The impact of these factors varies from one Nordic country to the next.

Selenium is an essential trace element. The human body cannot synthesize it. It must come from the diet and supplements. Selenium is a vital component of selenoproteins that are critical to normal health and physiological functioning. This is the fundamental message from a 2023 selenium scoping review conducted for the Nordic Nutritional Recommendations 2023 [Alexander & Olsen 2023]. read more

Selenium Delays Cognitive Decline

In the Swedish KiSel-10 clinical trial, the study participants had an average age of 78 years at the start of the study [Alehagen 2013]. Their serum selenium concentration at baseline was at a deficiency level (mean: 67.1 mcg/L).

Woman meditating
Diet, exercise, and meditation are all important to good brain health. Dietary and supplemental selenium crosses the blood-brain barrier. Supply of selenium to the brain has a higher priority than supply to other organs. Low selenium status is associated with cognitive decline.

Moreover, the low selenium status of the elderly Swedish citizens was significantly associated with relatively high mortality risk [Alehagen 2016]. Daily supplementation with 200 mcg of a selenium-enriched yeast preparation together with 200 mg of Coenzyme Q10 raised the study participants’ serum selenium levels to 210 mcg/L and reduced the risk of cardiovascular mortality [Alehagen 2022a].

The four years of joint supplementation were associated with the following positive health outcomes: read more